DiogenX
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
B2X
Company Operating Status
Active
Country
Crunchbase URL
Founded Date
January 1, 2019
Full Address
180 avenue du Prado 13008 Marseille
0
Parc Valrose – Centre de Biochimie 06108 Nice cedex 2 France
0
Headquarters
Investors
Latest Funding Round Date
May 10, 2023
Latest Funding Round Amount (USD)
30,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Pitchbook URL
Total Funding Amount (USD)
35,100,000
Official Website
Find more companies like DiogenX
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.